Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Awaiting India’s approval for COVISHIELD: SII
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March
HMD completes order of 140 mn KOJAK AD Syringes for global COVID-19 vaccination campaigns
The company has shipped the last batch of 35 million pieces of KOJAK Auto Disable Syringes to Covax stockpile facility via UNICEF
Zydus gets DCGI approval for Saroglitazar Mg to treat non-alcoholic fatty liver disease
Saroglitazar Mg is already approved for the treatment of type-2 diabetes and NASH
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021
Vaccines in pipeline will work against the new COVID-19 variants: Dr K Raghavan
Committee of experts to soon give report on the process of identifying and prioritising patients with co-morbidities, for the…
Pharmexcil submits recommendations for Foreign Trade Policy 2020-2025 to Commerce Ministry
It has highlighted key challenges faced by the pharma industry which require course corrections for creating a holistic and a…
CEPI to help advance development and manufacture of COVID-19 vaccine from Biological E
CEPI will initially contribute up to $5 million toward the cost of scaling up the process for manufacturing the vaccine, and will…
Dr Harsh Vardhan nominated to the Board of GAVI, The Vaccine Alliance
Dr Vardhan will be representing the SEARO/WPRO constituency on the GAVI Board
Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes
The FDC will be marketed under two brand names, Remo V and Remozen V, priced at Rs 14 per tab and Rs 28 per day cost of therapy